INTRODUCTION
Morphoea, also known as localised scleroderma, is a relatively rare disease characterised by excessive collagen deposition, leading to thickening of the dermis or subcutaneous tissues. It results from an imbalance between collagen deposition and destruction, but the disease's exact pathogenesis is not entirely understood. The prevalence of morphoea is equal in children and adults. Although the clinical course of this disease is benign, widespread fibrosis with resultant disabling contractures may lead to significant morbidity and complications. As such, it is crucial to promptly diagnose linear morphoea, as early intervention can prevent such complications. This report highlights a case of linear morphoea that was initially diagnosed as reflex sympathetic dystrophy.
Linear morphoea was subsequently identified and treated, but treatment was complicated by disabling contractures.
CASE REPORT
A 22-year-old healthy, Chinese, male fighter pilot with no significant medical history presented with thickening of the skin, discolouration of the left arm and contractures of the fingers over a period of ten months. He initially presented to an orthopaedic surgeon with complaints of a tightening sensation over his triceps.
As he gave a history of a possible mild injury (without fracture) during a golf game, he was diagnosed with reflex sympathetic dystrophy and treated with painkillers and physiotherapy. There was, however, no history of pain or burning sensation, or any history suggestive of vasomotor instability. Over the next ten months, the patient's condition worsened despite active physiotherapy. With a confirmed diagnosis of linear morphoea, our patient was started on topical protopic and clobetasol, and concurrently treated with ultraviolet A1 (UVA1) phototherapy twice a week.
After six months of treatment, his condition stabilised with no further progression of his fibrosis. There was also a slight improvement in the flexibility of his elbow and finger movements.
As a fighter pilot then, the patient was unwilling to consider taking hydroxychloroquine, as it might affect his vision and consequently, his career. ABSTRACT Morphoea, or localised scleroderma, is a disease entity with poorly understood pathogenesis. Early diagnosis of the condition is crucial in order to prevent permanent morbidity. However, initial presentations of morphoea can be nonspecific and easily mistaken for other conditions, resulting in late treatment and permanent disability. We report a case of linear morphoea in a 22-year-old man who was initially diagnosed with reflex sympathetic dystrophy. By the time the diagnosis of morphoea was confirmed, the patient had already developed contractures.
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DISCUS SION
Also known as localised scleroderma, morphoea is a rare condition with an incidence of 0.4-2.7 per 100,000 people. (1, 2) It is most often found in children aged 2-14 years old (3) and in adults aged 20-40 years old. (8) and imiquimod, (9) which may work via an C a s e R e p o r t e52 inhibitory effect on T-lymphocyte activation (8) and an increase in interferon-gamma (inhibits transforming growth factor beta and production of the extracellular matrix), (9) respectively.
Phototherapy with UVA1 (340-400 nm) has been presumed to work via the upregulation of the production of matrix metalloproteinases by fibroblasts that degrade collagen, and also via the immunomodulation of cytokines. (10) The efficacy of UVA1 phototherapy in the treatment of morphoea is widely agreed upon. (11) Systemic therapy with methotrexate and corticosteroids is used in patients with severe disease. (11) However, the rarity of morphoea and the scarcity of validated outcome measures limit the availability of evidence-based treatment options for this disease.
Besides managing the existing disease, monitoring for extracutaneous manifestations and early referral are also pertinent, for example, it is important to check for arthritis and neurologic This case demonstrates the importance of early recognition of features of linear morphoea so that treatment may be instituted early to prevent progression of the condition to disabling contractures, which unfortunately, happened in our case.
While the presentation of linear morphoea and reflex sympathetic dystrophy may be similar in some aspects, the absence of pain, swelling and vasomotor instability, coupled with the involvement of only a small part of the extremity, should alert clinicians to the diagnosis of linear morphoea. A biopsy should be done for early confirmation of the diagnosis and institution of treatment.
